Skip to main content
. 2015 Oct;22(5):e349–e356. doi: 10.3747/co.22.2337

TABLE IV.

Adverse effects with bevacizumab in elderly patients 70 or more years of age

Line of treatment Pts (n/N) Effecta

Arterial thrombosis Venous thrombosis Visceral perforation
First 35/80 3 (9) 3 (9) 0 (0)
Second 13/34 1 (8) 1 (8) 1 (8)
TOTAL 46/80 4 (8.7) 4 (8.7) 1(2.2)
a

Hypertension, proteinuria, and poor wound healing could not be collected retrospectively.